Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Lucideric acid A

🥰Excellent
Catalog No. TN1879Cas No. 95311-94-7
Alias Lucidenic acid A

Lucideric acid A (Lucidenic acid A) is a modulator of JNK and p38 and enhances LPS-induced immune responses in monocytic THP-1 cells possibly via the modulation of p38 and JNK/MAPKs activation.

Lucideric acid A

Lucideric acid A

🥰Excellent
Purity: 98.05%
Catalog No. TN1879Alias Lucidenic acid ACas No. 95311-94-7
Lucideric acid A (Lucidenic acid A) is a modulator of JNK and p38 and enhances LPS-induced immune responses in monocytic THP-1 cells possibly via the modulation of p38 and JNK/MAPKs activation.
Pack SizePriceAvailabilityQuantity
1 mg$39In Stock
5 mg$193In Stock
10 mg$283In Stock
25 mg$482In Stock
50 mgInquiryIn Stock
1 mL x 10 mM (in DMSO)$222In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Lucideric acid A"

Select Batch
Purity:98.05%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Lucideric acid A (Lucidenic acid A) is a modulator of JNK and p38 and enhances LPS-induced immune responses in monocytic THP-1 cells possibly via the modulation of p38 and JNK/MAPKs activation.
In vitro
Here, we showed that triterpenes-rich extract of antlered form of G. lucidum (G. lucidum AF) induces TNFα± production in monocytic THP-1 cells. Furthermore, the extract also synergized with lipopolysaccharide (LPS) to induce TNFα± production in THP-1 cells, suggesting an immunostimulatory role of triterpenes-rich extract of G. lucidum AF. Notably, the extract enhanced LPS-induced phosphorylation of p38 mitogen-activated protein kinase (MAPK), while it suppressed LPS-induced phosphorylation of c-Jun N-terminal kinase (JNK) MAPK. p38 Inhibitor suppressed TNFα± production, while JNK inhibitor enhanced TNFα± production, implying that synergistic effect of the extract may work by modulating p38 and JNK MAPKs. Moreover, we found that the triterpenes-rich extract of G. lucidum AF contains high amounts of lucidenic acids. Lucidenic acid-A, -F and -D(2), which seem to dominantly exist in the extract, were purified from the triterpenes-rich extract. We also identified Lucidenic acid-A and -F as modulators of JNK and p38, respectively[1]
AliasLucidenic acid A
Chemical Properties
Molecular Weight458.59
FormulaC27H38O6
Cas No.95311-94-7
Smiles[H][C@@]1(CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@]1([H])C[C@@H]3O)[C@H](C)CCC(O)=O
Relative Density.1.22±0.1 g/cm3 (20 °C, 760 mmHg)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 60 mg/ml (130.84 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1806 mL10.9030 mL21.8060 mL109.0299 mL
5 mM0.4361 mL2.1806 mL4.3612 mL21.8060 mL
10 mM0.2181 mL1.0903 mL2.1806 mL10.9030 mL
20 mM0.1090 mL0.5451 mL1.0903 mL5.4515 mL
50 mM0.0436 mL0.2181 mL0.4361 mL2.1806 mL
100 mM0.0218 mL0.1090 mL0.2181 mL1.0903 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Lucideric acid A | purchase Lucideric acid A | Lucideric acid A cost | order Lucideric acid A | Lucideric acid A chemical structure | Lucideric acid A in vitro | Lucideric acid A formula | Lucideric acid A molecular weight